Clinical Trials Directory

Trials / Completed

CompletedNCT02185677

Cognitive and Behavioral Dysexecutive Syndrome in Multiple System Atrophy

Comparison of Cognitive and Behavioral Dysexecutive Syndrome Between Parkinsonian Form and Cerebellar Form of Multiple System Atrophy and Analysis of Correlates With an Imaging Study.

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to compare the score to the Behavioral Dysexecutive Syndrome Inventory (BDSI) between Parkinsonian Multiple system Atrophy MSA-P patients and cerebellar Multiple System Atrophy (MSA-C) patients matched on disease duration, age (± 7 years) and sex .

Detailed description

Multiple system atrophy (MSA) is a rare neurodegenerative disorder which is characterized by a variable combination of parkinsonism, cerebellar dysfunction, autonomic failure, and additional signs. According to the consensus criteria for the diagnosis of MSA, the presence of dementia is considered an exclusion criteria. However, several studies have reported cognitive impairment in patients with MSA, dominated by a dysexecutive syndrome. Some studies have compared the cognitive profile of MSA-P patients and MSA-C but any have studied the behavioral dysexecutive syndrome in this population. In 2010, the GREFFEX has established criteria for dysexecutive syndrome and described two distinct parts: the dysexecutive syndrome and cognitive behavioral dysexecutive syndrome. Our clinical impression is that according to the type of MSA, the dysexecutive syndrome seems to be different : the MSA-P patients seem to have a cognitive dysexecutive syndrome and the MSA-C patients a behavioral dysexecutive syndrome. We want to compare the BDSI score between MSA-P patients and MSA-C patients matched on disease duration, age and sex The specific involvement of the cerebellum in behavioral disorders could explain the behavioral differences experienced by clinicians caring for these patients but never demonstrated. The presence of these disorders could have an impact on the relationship between the patient and the caregiver. In addition, few studies have correlated with cognitive imagery data. Therefore, the exact areas involved in cognitive and behavioral MSApatients remain poorly understood.

Conditions

Interventions

TypeNameDescription
OTHERClinical evaluation
OTHERneuropsychological battery test
OTHERMRI
OTHERActigraphyActigraphy recording will be performed during 7 days after inclusion.

Timeline

Start date
2014-05-14
Primary completion
2015-06-25
Completion
2015-06-26
First posted
2014-07-09
Last updated
2019-02-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02185677. Inclusion in this directory is not an endorsement.